Drug Design and Identification of Potent Leads Against Mycobacterium tuberculosis Thymidine Monophosphate Kinase

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|12|7|694-705

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.12, Iss.7, 2012-04, pp. : 694-705

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances towards identification of new drug targets for Mycobacterium tuberculosis

By Sharma Kirti   Chopra Puneet   Singh Yogendra  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. : 79-93

Informa Healthcare

Access to resources Recommend Favorite

Derivatives of 3-Isoxazolecarboxylic Acid Esters - A Potent and Selective Compound Class against Replicating and Nonreplicating Mycobacterium tuberculosis

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 7, 2012-04 ,pp. : 729-734

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms of bacterial acetohydroxyacid synthase (ahas) and specific inhibitors of Mycobacterium tuberculosis ahas as potential drug candidates against tuberculosis

By  

Current Drug Targets, Vol. 16, Iss. 7, 2015-01 ,pp. : 689-699

Bentham Science Publishers

Access to resources Recommend Favorite

Exploring Pyrimidine Pharmacophore as Thymidine Monophosphate Kinase Inhibitors for Antitubercular Activity: A Review

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 28, 2016-09 ,pp. : 3211-3223

Bentham Science Publishers

Access to resources Recommend Favorite

Fluorinated Compounds Against Mycobacterium tuberculosis

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 22, 2013-11 ,pp. : 2885-2904

Bentham Science Publishers

Access to resources Recommend Favorite